Patton Fund Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,264
Closed -$272K 333
2026
Q1
$272K Buy
+2,264
New +$261K 0.05% 219
2025
Q4
Sell
-3,051
Closed -$256K 493
2025
Q3
$256K Hold
3,051
0.05% 242
2025
Q2
$242K Buy
+3,051
New +$243K 0.05% 231
2023
Q3
Sell
-28,905
Closed -$3.34M 88
2023
Q2
$3.34M Buy
28,905
+13,497
+88% +$1.53M 0.97% 34
2023
Q1
$1.64M Sell
15,408
-10,597
-41% -$1.14M 0.47% 55
2022
Q4
$2.88M Sell
26,005
-505
-2% -$51.6K 0.84% 22
2022
Q3
$2.28M Sell
26,510
-1,018
-4% -$90.9K 0.93% 22
2022
Q2
$2.51M Buy
+27,528
New +$2.44M 0.94% 16

Other funds holding MRK

Patton Fund Management's MRK Position: Q2 2026 in Review

Patton Fund Management sold out of Merck (MRK) in Q2 2026, closing a stake of 2,264 shares — an estimated $272K sold.

Patton Fund Management first reported a position in MRK in Q2 2022 and held it in 8 quarters. The position peaked at $3.34M in Q2 2023. 1,575 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Patton Fund Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 2,264 Merck shares in Q2 2026, an estimated $272K.
  • Patton Fund Management first reported a position in Merck in Q2 2022 and held it in 8 quarters.
  • Patton Fund Management's Merck position peaked at $3.34M in Q2 2023.
  • 1,575 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.